Skip to main content
. 2018 Mar 19;2018:2654572. doi: 10.1155/2018/2654572

Table 2.

Overall survival and cancer-specific survival by therapeutic modality, adapted from Culp et al. (2014) [13].

Therapeutic modality 5-year OS rate (%) 5-year CSS rate (%)
RP 67,4 75,8
BT 52,6 61,3
NLT 22,5 48,7

OS: overall survival; CSS: cancer-specific survival; RP: radical prostatectomy; BT: brachytherapy; NLT: no local treatment.